DrugRepV_0103 | Oxibendazole | Antiparasitic | Helminth intestinal infections | Zika virus | Mex2-81 | NA | Immunoflourescence assay | Decrease (50 %) | Investigational, Vet approved | 28099856 |
DrugRepV_0546 | Oxibendazole | Antiparasitic | Helminth intestinal infections | Ebola virus | EBOVBlaVP40 | NA | Fluorescence-based assay | Decrease (50 %) | Investigational, Vet approved | 26038505 |
DrugRepV_2183 | Oxfendazole | Antiparasitic | Protects livestock from roundworm. strongyles, and pinworn | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (13.9350528 %) | Approved | 27742486 |
DrugRepV_2230 | Oxibendazole | Antiparasitic | Helminth intestinal infections | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (6.98667471 %) | Investigational, Vet approved | 27742486 |
DrugRepV_2435 | Sulfadoxine | Antiparasitic | Malaria | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (1.46534855 %) | Approved, Investigational | 27742486 |
DrugRepV_5504 | Selamectin | Antiparasitic | Vet-Antihelminthic | SARS Coronavirus-2 | GX_P2V/pangolin/2017/Guangxi | NA | qRT-PCR | Decrease | Vet approved | 32149769 |
DrugRepV_5726 | Bebeerine | Antiparasitic | Malaria | Dengue virus | New Guinea C | | Fluorescence-based assay | Decrease (50 %) | NA | 20973722 |
DrugRepV_5733 | Selamectin | Antiparasitic | Vet-Antihelminthic | Dengue virus | New Guinea C | | Fluorescence-based assay | Decrease (50 %) | Vet approved | 20973722 |
DrugRepV_5887 | Apoquinine | Antiparasitic | Malaria | Dengue virus | NA | | Plaque assay | Decrease (38 %) | NA | 24680954 |
DrugRepV_7065 | Apoquinine | Antiparasitic | Malaria | West Nile virus | NA | | Plaque assay | Decrease (56 %) | NA | 24680954 |
DrugRepV_7651 | Sulfadoxine | Antiparasitic | Malaria | SARS Coronavirus-2 | BavPat1 | NA | RT-PCR | Decrease (50 %) | Approved, Investigational | 32438446 |